• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by LifeStance Health Group Inc.

    11/7/25 11:13:45 AM ET
    $LFST
    Medical/Nursing Services
    Health Care
    Get the next $LFST alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 7)


    LIFESTANCE HEALTH GROUP INC

    (Name of Issuer)


    COMMON STOCK

    (Title of Class of Securities)


    53228F101

    (CUSIP Number)


    10/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    53228F101


    1Names of Reporting Persons

    FMR LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    39,239,105.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    39,249,054.02
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    39,249,054.02
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    10.1 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP No.
    53228F101


    1Names of Reporting Persons

    Abigail P. Johnson
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    39,249,054.02
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    39,249,054.02
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    10.1 %
    12Type of Reporting Person (See Instructions)

    IN


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    LIFESTANCE HEALTH GROUP INC
    (b)Address of issuer's principal executive offices:

    4800 N. SCOTTSDALE ROAD,SUITE 2500,SCOTTSDALE,AZ,USA,85251
    Item 2. 
    (a)Name of person filing:

    FMR LLC
    (b)Address or principal business office or, if none, residence:

    245 Summer Street, Boston, Massachusetts 02210
    (c)Citizenship:

    Not applicable
    (d)Title of class of securities:

    COMMON STOCK
    (e)CUSIP No.:

    53228F101
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    39249054.02
    (b)Percent of class:

    10.1  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    Please see the responses to Items 5 and 6 on the cover page.

     (ii) Shared power to vote or to direct the vote:

    0.00

     (iii) Sole power to dispose or to direct the disposition of:

    39249054.02

     (iv) Shared power to dispose or to direct the disposition of:

    0.00

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of LIFESTANCE HEALTH GROUP INC. No one other person's interest in the COMMON STOCK of LIFESTANCE HEALTH GROUP INC is more than five percent of the total outstanding COMMON STOCK.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    See attached Exhibit 99.
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    FMR LLC
     
    Signature:Stephanie J. Brown
    Name/Title:Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
    Date:11/06/2025
     
    Abigail P. Johnson
     
    Signature:Stephanie J. Brown
    Name/Title:Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
    Date:11/06/2025

    Comments accompanying signature:  * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
    Exhibit Information

    Please see Exhibit 99 for 13d-1(k) (1) agreement.

    Get the next $LFST alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LFST

    DatePrice TargetRatingAnalyst
    7/25/2025$8.00Buy
    BTIG Research
    5/27/2025$8.50Neutral → Buy
    UBS
    4/8/2025$9.00Overweight
    KeyBanc Capital Markets
    4/3/2025$8.00Buy
    Canaccord Genuity
    12/16/2024$10.00Neutral → Buy
    Goldman
    1/3/2024$7.00Underweight
    Barclays
    5/15/2023$8.00 → $9.00Outperform → Market Perform
    TD Cowen
    1/6/2023$8.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $LFST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Burdick Kenneth A bought $498,294 worth of shares (114,181 units at $4.36), increasing direct ownership by 2% to 3,436,571 units (SEC Form 4)

    4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

    8/12/25 4:30:22 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on LifeStance Health Group with a new price target

    BTIG Research initiated coverage of LifeStance Health Group with a rating of Buy and set a new price target of $8.00

    7/25/25 9:06:51 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    LifeStance Health Group upgraded by UBS with a new price target

    UBS upgraded LifeStance Health Group from Neutral to Buy and set a new price target of $8.50

    5/27/25 9:06:20 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    KeyBanc Capital Markets initiated coverage on LifeStance Health Group with a new price target

    KeyBanc Capital Markets initiated coverage of LifeStance Health Group with a rating of Overweight and set a new price target of $9.00

    4/8/25 9:29:32 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nearly 7 in 10 Americans Feel Pressure to Appear Happier Than They Are This Holiday Season

    LifeStance Survey Reveals How the Holidays Affect Mental Health, with Stress and Social Pressure Hitting Millennials and Gen Z Hardest SCOTTSDALE, Ariz., Nov. 5, 2025 /PRNewswire/ -- Findings from a LifeStance Health survey released today reveal that for many Americans, the holiday season involves a complex mix of emotions, including reported feelings of stress and pressure. These trends are particularly pronounced among younger generations. The survey explored topics commonly addressed in therapy around the holidays, including seasonal stress, navigating social gatherings, pe

    11/5/25 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    LifeStance to Present at the UBS Global Healthcare Conference

    SCOTTSDALE, Ariz., Oct. 28, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming UBS Global Healthcare Conference, which will be hosted in Palm Beach Gardens, FL. Details of the presentation are as follows:Presenter: Dave Bourdon, CEODate: Monday, November 10, 2025 Time: 4:15 p.m. (Eastern time)Moderated by: Kevin Caliendo The presentation will be webcast live and will be available on the Events and Presentations section of the LifeStance Health Investor Relations website (https://investor.lifestance.com).   A replay of the webcast will be

    10/28/25 4:10:00 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Calm Health Partners with LifeStance Health to Help Users Access High-Quality Mental Health Care

    Collaboration Will Simplify and Streamline Users' Ability to Find Personalized Care Delivered by Licensed Mental Health Clinicians PALO ALTO, Calif. and SCOTTSDALE, Ariz., Oct. 28, 2025 /PRNewswire/ -- Calm Health, Calm's evidence-based mental health app available through health plans, providers and employers, today announced it has partnered with LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care. Through this partnership, Calm Health users can now be guided directly to LifeStance for mental health care when higher-acuity treatment is recommended, making it easier to access trusted support for a variety of mental health conditions

    10/28/25 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    SEC Filings

    View All

    $LFST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by LifeStance Health Group Inc.

    SCHEDULE 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/7/25 11:13:45 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by LifeStance Health Group Inc.

    10-Q - LifeStance Health Group, Inc. (0001845257) (Filer)

    11/6/25 4:29:44 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by LifeStance Health Group Inc.

    SCHEDULE 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/5/25 11:40:14 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Director Personette Sarah was granted 74,766 shares (SEC Form 4)

    4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

    10/28/25 8:37:28 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    SEC Form 3 filed by new insider Personette Sarah

    3 - LifeStance Health Group, Inc. (0001845257) (Issuer)

    10/28/25 8:33:35 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Chief People Officer Varanakis Ann covered exercise/tax liability with 5,233 shares, decreasing direct ownership by 1% to 369,335 units (SEC Form 4)

    4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

    8/27/25 6:52:31 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    Leadership Updates

    Live Leadership Updates

    View All

    Sarah Personette Appointed to LifeStance Board of Directors

    Director William Miller to Step Down SCOTTSDALE, Ariz., Aug. 22, 2025 /PRNewswire/ -- LifeStance Health (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced the appointment of Sarah Personette, an accomplished customer experience, media and technology executive, to the company's board of directors, effective today. William Miller, Wellsky Chairman and CEO, will step down from the board after five years of service. "Sarah's longstanding focus on understanding consumer behavior to improve the customer experience parallels our com

    8/22/25 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    LifeStance Names Vaughn Paunovich as Chief Technology Officer

    SCOTTSDALE, Ariz., May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. Paunovich will lead LifeStance's end-to-end technology strategy, ensuring that the organization continues to deliver a best-in-class technology experience for its patients and clinicians. "Vaughn brings a demonstrated track record of leading high-performing technology teams and delivering digital exp

    5/14/25 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

    Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

    5/7/25 2:00:00 PM ET
    $CNC
    $LFST
    Medical Specialities
    Health Care
    Medical/Nursing Services

    $LFST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

    SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/14/24 4:34:15 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

    SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/14/24 9:59:56 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

    SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/8/24 4:33:25 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    Financials

    Live finance-specific insights

    View All

    LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025

    SCOTTSDALE, Ariz., Oct. 16, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter 2025 earnings release before the market opens on Thursday, November 6, 2025. LifeStance will host a live earnings conference call to discuss third quarter results on November 6, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 3958273, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance In

    10/16/25 4:10:00 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    LifeStance to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025

    SCOTTSDALE, Ariz., July 17, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter 2025 earnings release before the market opens on Thursday, August 7, 2025. LifeStance will host a live earnings conference call to discuss second quarter results on August 7, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 1294873, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Inve

    7/17/25 4:10:00 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

    SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2025 earnings release before the market opens on Wednesday, May 7, 2025. LifeStance will host a live earnings conference call to discuss first quarter results on May 7, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 6060781, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor R

    4/21/25 4:10:00 PM ET
    $LFST
    Medical/Nursing Services
    Health Care